Would you continue or stop anticoagulation for a DVT/PE in a patient with active cancer who has completed 6 months of therapy?   

This is an important question that we didn’t really have a clear answer for… until this year when an NEJM RCT was published! Mahé et al., PMID 40162636 In this RCT, patients with cancer-associated VTE who completed 6 months of full-dose apixaban were randomized to half-...

Important information. Very nice that the information is recent and finds that half-dose Eliquis is sufficient after treatment of VTE in cancer patients.